DM199 not checked

DiaMedica Therapeutics Inc

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2/3 trial completes
Trials
1 active
4 in total · 1 in the EU
Targets
 

What this is

How it works
How it works isn't classified yet
How it’s given
“Placebo administered by a single intravenous (IV) dose followed by subcutaneous (SC) doses at 2 hours (+10 hours) of the IV dose completion and then 2 times per week up to Day 21.”In the company’s words, NCT05065216 on ClinicalTrials.gov
Tested for
Acute Stroke, Ischemic Stroke, Stroke
Main trialPhase 2/3
“This is a Phase 2/3 study evaluating the safety and efficacy of DM199 (rinvecalinase alfa) in treating participants with moderate stroke severity, who present within 24 hours of Acute Ischemic Stroke (AIS) onset due to small and medium vessel occlusions. This study focuses on participants with limited treatment options. Participants who have or will receive mechanical thrombectomy (MT) are not eligible for participation. Additionally, participants who have received fibrinolytics are excluded unless they experience a persistent neurological deficit of moderate severity six or more hours after…”In the company’s words, NCT05065216 on ClinicalTrials.gov

Other drugs for Acute Stroke

All 54 drugs for Acute Stroke

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials4

TrialPhaseCompletesWhat it tests
Phase 2/3Recruiting Dec 2026 Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
Phase 2Completed 23 Jan 2020 Evaluation to Assess Safety and Tolerability of DM199 in Subjects With Acute Ischemic Stroke
Phase 2Completed 16 Mar 2022 Multiple Doses of DM199 in Patients With Chronic Kidney Disease (REDUX)
Phase 1Completed 21 Jul 2019 Study to Assess PK, Safety and Tolerability in Patients With DM and CKD
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow DM199

Following is part of Solo: you see every change to DM199 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in